AHA Files Formal Opposition to HRSA 340B Rebate Model — FQHC/Hospital Alignment on 'Flawed Mechanism'
The American Hospital Association filed formal opposition to HRSA's 340B rebate model RFI on April 20, 2026 — the comment deadline — framing 'any rebate mechanism is flawed' and warning the shift will cost billions and jeopardize access for millions. AHA joins NACHC and PhRMA in opposing the rebate pilot.
The unified FQHC/hospital front strengthens the 340B defense as manufacturer rebate plans continue activating (Lilly, Novo already live; 9th plan effective April 1).
Primary source
American Hospital AssociationSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, April 20). AHA Files Formal Opposition to HRSA 340B Rebate Model — FQHC/Hospital Alignment on 'Flawed Mechanism'. Primary source: American Hospital Association. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/aha-hrsa-340b-rebate-opposition-april-20-2026
More in Lobbying & Advocacy
Jul 8
CMS Keeps the 35% Essential Community Provider Standard in the 2027 Marketplace Final Rule — a Rulemaking Win NACHC Fought For
Jun 25
California's Health-Ballot Deal Withdraws the Executive-Pay Cap and Union-Spending Countermeasure; Proposition 44 Remains
May 22
California Hospital Association Warns FQHC Closures Will Drive Up ED Visits — First Time Hospital Lobby Publicly Backs FQHC Sustainability
May 19
SEIU-UHW 90% Patient-Care Mandate QUALIFIES for Nov 3, 2026 California Ballot — Existential FQHC Governance Fight Now Confirmed